Glucose-Lösung Demo

Glucose-Lösung Demo is an intravenous solution for injection containing the carbohydrate glucose as its sole active ingredient. The preparation is supplied in a standard concentration (strength not specified) and is marketed in the European Union. It is classified as an excipient/carbohydrate and is prescribed as a nutritional supplement or energy source for patients requiring rapid glucose replacement. It is intended for use under medical supervision and is supplied in containers.

Glucose-Lösung Demo is used when rapid elevation of blood glucose is required or when glucose is needed as part of parenteral nutrition.

- Treatment of acute hypoglycemia in hospital settings. - Component of total parenteral nutrition formulations. - Support for fluid and electrolyte replacement when combined with appropriate electrolytes. - Energy source during prolonged fasting or surgical procedures. - Adjunct in diagnostic procedures that require controlled glucose infusion.

Intravenous administration of Glucose-Lösung Demo may be associated with a range of observed effects, most of which are related to the rapid increase in plasma glucose.

Common: - Transient hyperglycemia. - Mild nausea or vomiting. - Local irritation at the infusion site. - Headache or dizziness.

Serious: - Severe hyperglycemia with osmotic diuresis. - Hypersensitivity reactions such as rash or anaphylaxis. - Electrolyte imbalance, particularly hyponatremia. - Fluid overload leading to pulmonary edema.

Before initiating therapy with Glucose-Lösung Demo, clinicians should evaluate patient-specific factors and monitor relevant parameters to minimize risks.

- Assess baseline blood glucose and adjust infusion rate accordingly. - Use caution in patients with diabetes mellitus or impaired insulin secretion. - Monitor serum electrolytes, especially sodium and potassium, during prolonged infusion. - Evaluate fluid status to avoid overload in patients with cardiac or renal insufficiency. - Verify compatibility with other intravenous solutions before mixing. - Consider pregnancy status; data on safety are limited. - Ensure aseptic technique to prevent catheter‑related infections.

Glucose-Lösung Demo can interact with other intravenously administered agents, influencing glucose metabolism or solution compatibility.

Avoid: - Co‑administration with high‑dose insulin infusions without appropriate glucose monitoring. - Mixing with calcium‑containing solutions that may precipitate. - Concurrent use of hypertonic dextrose solutions that could cause excessive hyperglycemia.

Use with caution: - Concurrent administration of diuretics that affect electrolyte balance. - Concurrent use of beta‑adrenergic agonists that may raise blood glucose. - Co‑infusion with medications that require strict pH control, such as certain antibiotics.